Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2018-01-03 Director's Dealing
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2018-01-03 English
PRIMARY DOCUMENT
Director's Dealing
2017-12-06 English
PRIMARY DOCUMENT
Director's Dealing
2017-11-17 English
FORM 4 SUBMISSION
Director's Dealing
2017-11-07 English
10-Q
Interim / Quarterly Report Q3 2017
2017-11-02 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 25, 2017, reporting the issuance of an earnings press release for the quarterly period ended September 30, 2017. The text explicitly states that the press release is furnished as an exhibit to the report and contains non-GAAP financial measures. The document itself is a current report announcing the earnings release, not the earnings release document itself. The length is about 6,041 characters, which is relatively short and consistent with an announcement rather than a full report. According to the classification rules, initial announcements of quarterly financial results (key highlights only) correspond to Earnings Release (ER). Since this is a Form 8-K announcing the earnings release and including the press release as an exhibit, it fits best as an Earnings Release (ER) filing type rather than a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2017-10-25 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.